Download the Free Prime PubMed App to your smartphone or tablet.

Available for iPhone or iPad:

Unbound PubMed app for iOS iPhone iPadAlso Available:
Unbound PubMed app for Android

Available for Mac and Windows Desktops and laptops:

Unbound PubMed app for WindowsUnbound PubMed app for MAC OS Yosemite Macbook Air pro
(Angiotensin II receptor blockers)
30,317 results
  • Low body mass index is a risk factor for hyperkalaemia associated with angiotensin converting enzyme inhibitors and angiotensin II receptor blockers treatments. [Journal Article]
  • JCJ Clin Pharm Ther 2018 Jun 16
  • Hirai T, Yamaga R, … Itoh T
  • CONCLUSIONS: The study included 2987 patients aged 70.1 ± 12.9 years, 61.0% were men, and BMI was 23.8 ± 4.4 kg/m2 . The incidence of hyperkalaemia was 7.8%. Multivariable logistic regression analysis revealed that age >65 years, low BMI, diabetes, history of treatment for hyperkalaemia, serum sodium <135 meq/L, eGFR <30 mL/min/1.73m2 and the concomitant use of hyperkalaemia-inducing medications were independent risk factors for hyperkalaemia associated with ACEI and ARB.This study demonstrated that BMI provides useful information for the identification of potential risk for hyperkalaemia associated with ACEI and ARB treatments.
  • Resistant Hypertension in Pregnancy: How to Manage? [Review]
  • CHCurr Hypertens Rep 2018 Jun 11; 20(8):63
  • Bortolotto MR, Francisco RPV, Zugaib M
  • The concept of resistant hypertension may be changed during pregnancy by the physiological hemodynamic changes and the particularities of therapy choices in this period. This review discusses the man...
  • Treatment of Hypertension in Chronic Kidney Disease. [Review]
  • CHCurr Hypertens Rep 2018 Jun 11; 20(8):64
  • Kalaitzidis RG, Elisaf MS
  • Chronic kidney disease (CKD) is recognized as a worldwide epidemic. Hypertension commonly coexists with CKD and its prevalence is progressively increasing as kidney function declines.
New Search Next